|
Immunotherapy
Citations 431-440 of 577 total displayed.
|
Past content
(since Jun 2000):
|
Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies
- Stephen Gottschalk, Oliver L. Edwards, Uluhan Sili, M. Helen Huls, Tatiana Goltsova, Alan R. Davis, Helen E. Heslop, and Cliona M. Rooney
Blood 2003; 101: 1905-1912.
[Abstract]
[Full text]
[PDF]
Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation
- Kelli P. A. MacDonald, Vanessa Rowe, Cheryl Filippich, Ranjeny Thomas, Andrew D. Clouston, Joseph K. Welply, Derek N. J. Hart, James L. M. Ferrara, and Geoffrey R. Hill
Blood 2003; 101: 2033-2042.
[Abstract]
[Full text]
[PDF]
Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia
- Norbert Frickhofen, Hermann Heimpel, Joachim P. Kaltwasser, and Hubert Schrezenmeier
Blood 2003; 101: 1236-1242.
[Abstract]
[Full text]
[PDF]
Differential CD52 expression by distinct myeloid dendritic cell subsets: implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft-host interactions in transplantation
- Gudrun Ratzinger, John L. Reagan, Glenn Heller, Klaus J. Busam, and James W. Young
Blood 2003; 101: 1422-1429.
[Abstract]
[Full text]
[PDF]
Tetramer-assisted identification and characterization of epitopes recognized by HLA A*2402-restricted Epstein-Barr virus-specific CD8+ T cells
- Kiyotaka Kuzushima, Naomi Hayashi, Ayumi Kudoh, Yoshiki Akatsuka, Kunio Tsujimura, Yasuo Morishima, and Tatsuya Tsurumi
Blood 2003; 101: 1460-1468.
[Abstract]
[Full text]
[PDF]
Dendritic cells overexpressing CD95 (Fas) ligand elicit vigorous allospecific T-cell responses in vivo
- Sofia Buonocore, Frédéric Paulart, Alain Le Moine, Michel Braun, Isabelle Salmon, Sonja Van Meirvenne, Kris Thielemans, Michel Goldman, and Véronique Flamand
Blood 2003; 101: 1469-1476.
[Abstract]
[Full text]
[PDF]
T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect
- Laurence J. N. Cooper, Max S. Topp, Lisa Marie Serrano, Sergio Gonzalez, Wen-Chung Chang, Araceli Naranjo, Christine Wright, Leslie Popplewell, Andrew Raubitschek, Stephen J. Forman, and Michael C. Jensen
Blood 2003; 101: 1637-1644.
[Abstract]
[Full text]
[PDF]
Successful therapy of metastatic cancer using tumor vaccines in mixed allogeneic bone marrow chimeras
- Leo Luznik, Jill E. Slansky, Sanju Jalla, Ivan Borrello, Hyam I. Levitsky, Drew M. Pardoll, and Ephraim J. Fuchs
Blood 2003; 101: 1645-1652.
[Abstract]
[Full text]
[PDF]
Gene expression and immunologic consequence of SPAN-Xb in myeloma and other hematologic malignancies
- Zhiqing Wang, Yana Zhang, Haichao Liu, Emanuela Salati, Maurizio Chiriva-Internati, and Seah H. Lim
Blood 2003; 101: 955-960.
[Abstract]
[Full text]
[PDF]
Complement-mediated lysis by anti-CD20 mAb correlates with segregation into lipid rafts
- Mark S. Cragg, Suzanne M. Morgan, H. T. Claude Chan, B. Paul Morgan, A. V. Filatov, Peter W. M. Johnson, Ruth R. French, and Martin J. Glennie
Blood 2003; 101: 1045-1052.
[Abstract]
[Full text]
[PDF]
|
|
